Twist Bioscience Corporation - Common Stock (TWST)

Competitors to Twist Bioscience Corporation - Common Stock (TWST)

Amyris, Inc.

Amyris operates within the realm of synthetic biology as well, focusing on producing sustainable ingredients for various industries, including personal care and cosmetics, through its proprietary technology. Can be seen as competitors to Twist in terms of offering engineered biological solutions, although primarily in different applications. Its scalable production capabilities and experience in commercialization of bioproducts give Amyris an edge in sustainability-driven markets.

Codexis, Inc. 

Codexis designs and develops proteins and enzymes for pharmaceutical and other industrial applications, competing with Twist in the area of protein engineering and enzyme discovery. Both companies leverage synthetic biology to create innovative solutions, but Codexis benefits from a long-standing reputation in enzyme innovation and its established partnerships within the pharmaceutical sector, providing it leverage and trust within specific markets.

Ginkgo Bioworks, Inc. 

Ginkgo Bioworks specializes in organism engineering and utilizes a platform biotechnology approach that allows it to design and deploy custom organisms for a variety of applications including pharmaceuticals, agriculture, and specialty chemicals. Ginkgo competes with Twist by offering services that leverage advanced computational biology and a broader range of organism design capabilities. Ginkgo's large network and partnerships with various industries provide it with a strong competitive advantage in rapid development and deployment.

Illumina, Inc. 

Illumina is a leader in genomic sequencing and has a significant competitive advantage due to its extensive portfolio of products designed for DNA sequencing and analysis. While Twist focuses on DNA synthesis and synthesis-related services, Illumina leverages its advanced sequencing technologies to offer comprehensive genomic solutions. The companies compete in the overlap between DNA synthesis and sequencing technologies, where Illumina's established market presence and customer relationships give it an edge.

Synthego Corporation

Synthego focuses on synthetic RNA and CRISPR genome editing, providing innovative gene editing solutions that are highly integrated with advanced automation and cloud-based software systems. Their primary competition with Twist lies in the gene synthesis and editing markets, where Synthego's specialized focus on CRISPR technology has allowed it to gain a substantial foothold and cultivate a loyal customer base, giving it a competitive edge in targeted genome editing applications.